CVS Health Co. (NYSE:CVS) Shares Bought by Keynote Financial Services LLC

Keynote Financial Services LLC grew its holdings in shares of CVS Health Co. (NYSE:CVS - Free Report) by 14.2% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 32,385 shares of the pharmacy operator's stock after buying an additional 4,034 shares during the quarter. CVS Health accounts for approximately 1.1% of Keynote Financial Services LLC's holdings, making the stock its 23rd biggest holding. Keynote Financial Services LLC's holdings in CVS Health were worth $1,454,000 as of its most recent SEC filing.

Other institutional investors have also recently made changes to their positions in the company. Hotchkis & Wiley Capital Management LLC lifted its stake in shares of CVS Health by 34.8% in the 3rd quarter. Hotchkis & Wiley Capital Management LLC now owns 11,897,034 shares of the pharmacy operator's stock valued at $748,085,000 after purchasing an additional 3,071,613 shares during the last quarter. ARGA Investment Management LP boosted its stake in CVS Health by 7,567.7% during the fourth quarter. ARGA Investment Management LP now owns 2,402,901 shares of the pharmacy operator's stock worth $107,866,000 after buying an additional 2,371,563 shares during the period. State Street Corp increased its position in CVS Health by 3.6% during the third quarter. State Street Corp now owns 56,527,909 shares of the pharmacy operator's stock valued at $3,554,475,000 after acquiring an additional 1,989,066 shares during the last quarter. TOMS Capital Investment Management LP bought a new stake in shares of CVS Health in the 3rd quarter worth about $121,987,000. Finally, Mizuho Markets Americas LLC boosted its stake in shares of CVS Health by 1,470.2% during the 3rd quarter. Mizuho Markets Americas LLC now owns 1,396,464 shares of the pharmacy operator's stock worth $87,810,000 after purchasing an additional 1,307,531 shares during the period. Institutional investors own 80.66% of the company's stock.

Analyst Upgrades and Downgrades

Several analysts have issued reports on CVS shares. Wolfe Research raised their price objective on shares of CVS Health from 67.00 to 70.00 and gave the stock an "overweight" rating in a research note on Tuesday, February 11th. Deutsche Bank Aktiengesellschaft upgraded CVS Health from a "hold" rating to a "buy" rating and set a $66.00 price objective for the company in a report on Tuesday, December 3rd. StockNews.com upgraded CVS Health from a "sell" rating to a "hold" rating in a research note on Thursday, February 13th. Royal Bank of Canada lowered their target price on shares of CVS Health from $68.00 to $58.00 and set an "outperform" rating for the company in a research note on Friday, November 15th. Finally, Piper Sandler reduced their price target on shares of CVS Health from $72.00 to $64.00 and set an "overweight" rating on the stock in a research note on Monday, November 25th. Four research analysts have rated the stock with a hold rating, seventeen have issued a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat.com, CVS Health currently has a consensus rating of "Moderate Buy" and a consensus price target of $69.83.

Insider Buying and Selling at CVS Health

In related news, Director Michael F. Mahoney acquired 30,000 shares of the business's stock in a transaction dated Tuesday, February 18th. The shares were purchased at an average price of $66.70 per share, for a total transaction of $2,001,000.00. Following the completion of the acquisition, the director now directly owns 39,356 shares in the company, valued at $2,625,045.20. The trade was a 320.65 % increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 0.24% of the stock is currently owned by company insiders.

CVS Health Stock Down 0.9 %

CVS traded down $0.59 on Monday, hitting $65.13. The company had a trading volume of 2,919,759 shares, compared to its average volume of 12,306,433. The stock has a market capitalization of $82.12 billion, a price-to-earnings ratio of 17.81, a P/E/G ratio of 0.98 and a beta of 0.61. The company has a debt-to-equity ratio of 0.80, a quick ratio of 0.60 and a current ratio of 0.81. The stock has a fifty day moving average price of $54.33 and a 200-day moving average price of $56.47. CVS Health Co. has a 12-month low of $43.56 and a 12-month high of $80.75.

CVS Health (NYSE:CVS - Get Free Report) last posted its quarterly earnings data on Wednesday, February 12th. The pharmacy operator reported $1.19 EPS for the quarter, topping the consensus estimate of $0.89 by $0.30. CVS Health had a net margin of 1.24% and a return on equity of 9.11%. Analysts predict that CVS Health Co. will post 5.89 EPS for the current fiscal year.

CVS Health Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Monday, February 3rd. Investors of record on Thursday, January 23rd were given a dividend of $0.665 per share. This represents a $2.66 annualized dividend and a yield of 4.08%. The ex-dividend date was Thursday, January 23rd. CVS Health's dividend payout ratio is currently 72.68%.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.